Products
Data
Feature
Plans
Request Demo
Sign Up for Free
Blog
Valuable Targets
Advanced Tech.
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
Latest Hotspot
8 min read
CD72 Biologics Sequence Review Report 2026: B-cell differentiation antigen CD72 Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of CD72 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
CD63 Biologics Sequence Review Report 2026: CD63 antigen Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of CD63 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
CD5L Biologics Sequence Review Report 2026: CD5 antigen-like Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of CD5L protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
CD58 Biologics Sequence Review Report 2026: Lymphocyte function-associated antigen 3 Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of CD58 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
CD37 Biologics Sequence Review Report 2026: Leukocyte antigen CD37 Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of CD37 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
CD34 Biologics Sequence Review Report 2026: Hematopoietic progenitor cell antigen CD34 Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of CD34 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
CD320 Biologics Sequence Review Report 2026: CD320 antigen Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of CD320 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
CD302 Biologics Sequence Review Report 2026: CD302 antigen Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of CD302 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
CD2BP2 Biologics Sequence Review Report 2026: CD2 antigen cytoplasmic tail-binding protein 2 Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of CD2BP2 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
CD244 Biologics Sequence Review Report 2026: Natural killer cell receptor 2B4 Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of CD244 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
CD226 Biologics Sequence Review Report 2026: CD226 antigen Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of CD226 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
CD209 Biologics Sequence Review Report 2026: CD209 antigen Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of CD209 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
<
1
<<
91
92
93
94
95
>>
1503
>